These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34855244)

  • 1. Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab.
    Orte Cano C; Van Meerhaeghe T; Tannous J; Lienard D; Van Gestel D; Cuylits N; Luce S; Carlot S; Le Moine A; Aspeslagh S; Del Marmol V
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():53-58. PubMed ID: 34855244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma.
    Tsung I; Worden FP; Fontana RJ
    Oncologist; 2021 Feb; 26(2):133-138. PubMed ID: 32969143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of cemiplimab in progressive metastatic cutaneous squamous cell carcinoma after kidney transplantation: a case report.
    Geidel G; Rünger A; Schneider SW; Gebhardt C
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():49-52. PubMed ID: 34855252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
    Hanna GJ; Dharanesswaran H; Giobbie-Hurder A; Harran JJ; Liao Z; Pai L; Tchekmedyian V; Ruiz ES; Waldman AH; Schmults CD; Riella LV; Lizotte P; Paweletz CP; Chandraker AK; Murakami N; Silk AW
    J Clin Oncol; 2024 Mar; 42(9):1021-1030. PubMed ID: 38252908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe Administration of Cemiplimab to a Kidney Transplant Patient with Locally Advanced Squamous Cell Carcinoma of the Scalp.
    Paoluzzi L; Ow TJ
    Curr Oncol; 2021 Jan; 28(1):574-580. PubMed ID: 33477979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.
    Van Meerhaeghe T; Baurain JF; Bechter O; Orte Cano C; Del Marmol V; Devresse A; Doubel P; Hanssens M; Hellemans R; Lienard D; Rutten A; Sprangers B; Le Moine A; Aspeslagh S
    Front Nephrol; 2022; 2():1041819. PubMed ID: 37675002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
    Vidovic D; Simms GA; Pasternak S; Walsh M; Peltekian K; Stein J; Helyer LK; Giacomantonio CA
    Front Immunol; 2021; 12():678028. PubMed ID: 34122442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent liver injury from cemiplimab in patients with advanced cutaneous squamous cell carcinoma.
    Swanson L; Kassab I; Tsung I; Worden FP; Fontana RJ
    Immunotherapy; 2022 Apr; 14(6):409-418. PubMed ID: 35232282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
    Mokos M; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parotid metastases of cutaneous squamous cell carcinoma in renal transplant recipients: Case series and literature review.
    Mokos M; Bašić-Jukić N
    Dermatol Ther; 2021 May; 34(3):e14907. PubMed ID: 33619803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study.
    Salido-Vallejo R; Escribano-Castillo L; Antoñanzas J; Roldán-Córdoba C; Velez A; Aguado-Gil L
    J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma.
    Boutros A; Croce E; Tanda ET; Cecchi F; Arecco L; Genova C; Baldelli I; Lambertini M; Raposio E; Del Mastro L; Spagnolo F
    J Geriatr Oncol; 2024 Mar; 15(2):101640. PubMed ID: 37798175
    [No Abstract]   [Full Text] [Related]  

  • 13. Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience in a Monographic Oncology Center.
    Ríos-Viñuela E; Álvarez P; Lavernia J; Serra-Guillén C; Requena C; Bernia E; Diago A; Llombart B; Sanmartín O
    Actas Dermosifiliogr; 2022 Jun; 113(6):610-615. PubMed ID: 35431057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience in a Monographic Oncology Center.
    Ríos-Viñuela E; Álvarez P; Lavernia J; Serra-Guillén C; Requena C; Bernia E; Diago A; Llombart B; Sanmartín O
    Actas Dermosifiliogr; 2022 Jun; 113(6):T610-T615. PubMed ID: 35525283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of the Management of Cutaneous Squamous-cell Carcinoma.
    Maubec E
    Acta Derm Venereol; 2020 Jun; 100(11):adv00143. PubMed ID: 32346744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Checkpoint Inhibitors for Treating Advanced Cutaneous Squamous Cell Carcinoma.
    Patel R; Chang ALS
    Am J Clin Dermatol; 2019 Aug; 20(4):477-482. PubMed ID: 30737731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Administration of Cemiplimab to a Patient With Advanced Cutaneous Squamous Cell Carcinoma After Renal Transplantation.
    Ali SA; Arman HE; Patel AA; Birhiray RE
    JCO Oncol Pract; 2020 Mar; 16(3):137-138. PubMed ID: 31770056
    [No Abstract]   [Full Text] [Related]  

  • 18. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.
    Migden MR; Chandra S; Rabinowits G; Chen CI; Desai J; Seluzhytsky A; Sasane M; Campanelli B; Chen Z; Freeman ML; Ibrahim SF; Khushalani NI; Andria M; Ruiz E
    Future Oncol; 2020 Feb; 16(4):11-19. PubMed ID: 31951149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review.
    Banini M; Salvestrini V; Vultaggio A; Perlato M; Mecheri V; Cerbai C; Scotti V; Matucci A; Mangoni M; Livi L; Bonomo P
    Curr Oncol; 2023 Jul; 30(7):6699-6707. PubMed ID: 37504351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient.
    McLaughlin EJ; Miller L; Shin TM; Sobanko JF; Cannady SB; Miller CJ; Newman JG
    Am J Otolaryngol; 2017; 38(3):325-328. PubMed ID: 28202188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.